Literature DB >> 22177741

Symptom dimensions as predictors of the two-year course of depressive and anxiety disorders.

Klaas J Wardenaar1, Erik J Giltay, Tineke van Veen, Frans G Zitman, Brenda W J H Penninx.   

Abstract

BACKGROUND: Because of the heterogeneity of known predictive factors, course-predictions for depression and anxiety are often unspecific. Therefore, it was investigated whether symptom-dimensions could be used as more specific course-predictors, on top of already known predictors, such as diagnosis and overall severity.
METHODS: A sample of 992 subjects with depressive and/or anxiety disorders was followed in a 2-year prospective cohort study. Dimensions of the tripartite model (general distress, anhedonic depression and anxious arousal) were assessed at baseline. Diagnostic and course information were assessed at baseline and 2-year follow-up.
RESULTS: Dimensional scores at baseline predicted diagnosis after two years and course-trajectories during follow-up. Increased general distress at baseline was associated with comorbid depression-anxiety at follow-up, increased anhedonic depression was associated with single depression and anxious arousal was associated with (comorbid) panic disorders at follow-up. Baseline general distress was associated with an unfavorable course in all patients. All associations were independent and added prognostic information on top of diagnosis and other predictive factors at baseline. LIMITATIONS: Only prevalent patients were included at baseline and only three dimensions were measured
CONCLUSIONS: Symptom dimensions predict the future 2-year course of depression and anxiety. Importantly, the dimensions yield predictive information on top of diagnosis and other prognostic factors at baseline.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22177741     DOI: 10.1016/j.jad.2011.11.037

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  14 in total

1.  Is low positive emotionality a specific risk factor for depression? A meta-analysis of longitudinal studies.

Authors:  Gabriela Kattan Khazanov; Ayelet Meron Ruscio
Journal:  Psychol Bull       Date:  2016-07-14       Impact factor: 17.737

Review 2.  Motivation and cognitive control in depression.

Authors:  Ivan Grahek; Amitai Shenhav; Sebastian Musslick; Ruth M Krebs; Ernst H W Koster
Journal:  Neurosci Biobehav Rev       Date:  2019-05-27       Impact factor: 8.989

3.  The "Brightening" Effect: Reactions to Positive Events in the Daily Lives of Individuals With Major Depressive Disorder and Generalized Anxiety Disorder.

Authors:  Gabriela Kattan Khazanov; Ayelet Meron Ruscio; Joel Swendsen
Journal:  Behav Ther       Date:  2018-06-05

Review 4.  The promise of ketamine for treatment-resistant depression: current evidence and future directions.

Authors:  Kaitlin E DeWilde; Cara F Levitch; James W Murrough; Sanjay J Mathew; Dan V Iosifescu
Journal:  Ann N Y Acad Sci       Date:  2015-02-03       Impact factor: 5.691

5.  Sustained anterior cingulate cortex activation during reward processing predicts response to psychotherapy in major depressive disorder.

Authors:  Hannah Carl; Erin Walsh; Tory Eisenlohr-Moul; Jared Minkel; Andrew Crowther; Tyler Moore; Devin Gibbs; Chris Petty; Josh Bizzell; Gabriel S Dichter; Moria J Smoski
Journal:  J Affect Disord       Date:  2016-06-04       Impact factor: 4.839

Review 6.  Depression, stress, and anhedonia: toward a synthesis and integrated model.

Authors:  Diego A Pizzagalli
Journal:  Annu Rev Clin Psychol       Date:  2014       Impact factor: 18.561

7.  Change in functioning outcomes as a predictor of the course of depression: a 12-month longitudinal study.

Authors:  Carlos G Forero; Elena Olariu; Pilar Álvarez; José-Ignacio Castro-Rodriguez; Maria Jesús Blasco; Gemma Vilagut; Víctor Pérez; Jordi Alonso
Journal:  Qual Life Res       Date:  2018-04-10       Impact factor: 4.147

8.  Approach-Avoidance Conflict in Major Depressive Disorder: Congruent Neural Findings in Humans and Nonhuman Primates.

Authors:  Maria Ironside; Ken-Ichi Amemori; Callie L McGrath; Mads Lund Pedersen; Min Su Kang; Satoko Amemori; Michael J Frank; Ann M Graybiel; Diego A Pizzagalli
Journal:  Biol Psychiatry       Date:  2019-09-06       Impact factor: 13.382

9.  Impact of the KCNQ2/3 Channel Opener Ezogabine on Reward Circuit Activity and Clinical Symptoms in Depression: Results From a Randomized Controlled Trial.

Authors:  Sara Costi; Laurel S Morris; Katherine A Kirkwood; Megan Hoch; Morgan Corniquel; Brittany Vo-Le; Tabish Iqbal; Nisha Chadha; Diego A Pizzagalli; Alexis Whitton; Laura Bevilacqua; Manish K Jha; Stefan Ursu; Alan C Swann; Katherine A Collins; Ramiro Salas; Emilia Bagiella; Michael K Parides; Emily R Stern; Dan V Iosifescu; Ming-Hu Han; Sanjay J Mathew; James W Murrough
Journal:  Am J Psychiatry       Date:  2021-03-03       Impact factor: 18.112

10.  Major depressive disorder subtypes to predict long-term course.

Authors:  Hanna M van Loo; Tianxi Cai; Michael J Gruber; Junlong Li; Peter de Jonge; Maria Petukhova; Sherri Rose; Nancy A Sampson; Robert A Schoevers; Klaas J Wardenaar; Marsha A Wilcox; Ali Obaid Al-Hamzawi; Laura Helena Andrade; Evelyn J Bromet; Brendan Bunting; John Fayyad; Silvia E Florescu; Oye Gureje; Chiyi Hu; Yueqin Huang; Daphna Levinson; Maria Elena Medina-Mora; Yoshibumi Nakane; Jose Posada-Villa; Kate M Scott; Miguel Xavier; Zahari Zarkov; Ronald C Kessler
Journal:  Depress Anxiety       Date:  2014-01-14       Impact factor: 6.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.